Heart Disease Trial, Recruiting NCT07388342 Sponsor: Universitair Ziekenhuis Brussel Condition: Heart Disease
Back to Heart Disease

Heart Disease Trial, Recruiting

NCT07388342
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Adults aged 18 or older who have had a cardiac arrest (either inside or outside of a hospital) and whose heart has restarted on its own after treatment.
  • Informed consent has been given by the patient or their legal representative before any heart artery procedure is performed.

Who may not be able to join:

  • People who are on a specific life support machine that helps the heart and lungs pump blood (called VA-ECMO).
  • People who are having a particular type of serious heart attack (STEMI or STEMI "equivalent"), which is identified by specific patterns on a heart tracing (ECG), including certain changes to the electrical signals in the heart.
  • People having a type of heart attack (NSTEMI) where the heart is still being starved of blood despite the best available treatment, and the treating doctor considers an urgent heart artery procedure to be needed.
  • People whose heart rhythm or blood pressure is too unstable to safely undergo a CT scan, as judged by the treating doctor.
  • People experiencing a dangerous heart rhythm that the treating doctor believes is being caused by an active blockage in a heart artery.
  • People who have a known serious allergy or medical reason that means they cannot receive the dye used in CT or heart artery imaging (iodinated contrast).
  • People whose cardiac arrest is already known to have been caused by a non-heart-related reason — such as a serious head injury, heavy bleeding, lack of oxygen from a known lung condition, trauma, a severe chemical or salt imbalance in the body, or poisoning — and where the treating doctor considers a chest CT scan unnecessary.
  • People who are known or suspected to be pregnant, or who are breastfeeding.
  • People with a serious bleeding problem, as judged by the treating doctor, that would prevent the use of a blood-thinning medication (heparin) during a heart artery procedure performed through the wrist.
  • People who have previously had a stent placed in a heart artery or have had heart bypass surgery (CABG).
  • People whose CT scan results show a condition that means a heart artery procedure cannot be done in the near term.
  • People who are already receiving end-of-life care.
  • People who are already taking part in another clinical intervention study that would conflict with this trial.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Universitair Ziekenhuis Brussel
Registry
ClinicalTrials.gov
Start date
1 September 2025
Est. completion
1 September 2027

Where this trial is recruiting

🇧🇪 Belgium

Primary endpoints

Percentage of patients correctly classified to coronary artery disease as the cause of cardiac arrest after analysis of the CT scan

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov